Ian Howard - Net Worth and Insider Trading

Ian Howard Net Worth

The estimated net worth of Ian Howard is at least $4,500 dollars as of 2024-11-13. Ian Howard is the Director of Ovation Science Inc and owns about 150,000 shares of Ovation Science Inc (XCNQ:OVAT) stock worth over $4,500. Details can be seen in Ian Howard's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ian Howard has not made any transactions after 2020-07-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Ian Howard

Ian Howard Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ian Howard owns 1 companies in total, including Ovation Science Inc (XCNQ:OVAT) .

Click here to see the complete history of Ian Howard’s form 4 insider trades.

Insider Ownership Summary of Ian Howard

Ticker	Comapny	Transaction Date	Type of Owner
XCNQ:OVAT	Ovation Science Inc	2020-07-10	Director

Ian Howard Latest Holdings Summary

Ian Howard currently owns a total of 1 stock. Ian Howard owns 150,000 shares of Ovation Science Inc (XCNQ:OVAT) as of July 10, 2020, with a value of $4,500.

Latest Holdings of Ian Howard

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
XCNQ:OVAT	Ovation Science Inc	2020-07-10	150,000	0.03	4,500

Holding Weightings of Ian Howard

Ian Howard Form 4 Trading Tracker

According to the SEC Form 4 filings, Ian Howard has made a total of 7 transactions in Ovation Science Inc (XCNQ:OVAT) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Ovation Science Inc is the sale of 50,000 shares on July 10, 2020, which brought Ian Howard around $26,500.

Insider Trading History of Ian Howard

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ian Howard Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ian Howard Ownership Network

Ownership Network List of Ian Howard

No Data

Ownership Network Relation of Ian Howard

Ian Howard Owned Company Details

What does Ovation Science Inc do?

Who are the key executives at Ovation Science Inc?

Ian Howard is the Director of Ovation Science Inc.

Ovation Science Inc (XCNQ:OVAT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ovation Science Inc (XCNQ:OVAT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ovation Science Inc (XCNQ:OVAT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ovation Science Inc (XCNQ:OVAT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ovation Science Inc Insider Transactions

No Available Data

Ian Howard Mailing Address

Above is the net worth, insider trading, and ownership report for Ian Howard. Currently GuruFocus does not have mailing address information for Ian Howard.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.